Compare Charles Schwab Corporation Common Stock (SCHW) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles Schwab Corporation Common Stock vs Tenet Healthcare Corporation — how do they compare? Charles Schwab Corporation Common Stock trades at $97 (market cap $165.29B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 7.9× Tenet Healthcare Corporation's market cap, and Charles Schwab Corporation Common Stock pays a 1.34% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles Schwab Corporation Common Stock for 85 Days and Tenet Healthcare Corporation for 15 Days on average.
| SCHW | THC | |
|---|---|---|
Market Cap | $165.29B | $20.92B |
Volume | 7,114,246 | 455,764 |
Sector | Financials | Health |
52-Week High | $113.65 | $280.77 |
52-Week Low | $85.35 | $161.37 |
Typical Hold Time | 85 Days | 15 Days |
Enterprise Value | $151.73B | $32.00B |
Dividend Yield | 1.34% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles Schwab (SCHW) trades at $96.87, up 0.07% with bearish technical signals but strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $1.62 exceeding expectations of $1.56. Revenue grew to $23.92B in 2025 with 37% profit margin, while analyst consensus remains bullish with a $119.92 price target. Recent developments include dual listing on the Texas Stock Exchange and AI integration partnerships.
SCHW presents a compelling value opportunity with attractive valuation metrics (P/E 17.41) and strong profitability (ROE 22.45%). Near-term risks include technical bearish momentum and market volatility, but long-term growth prospects in the expanding e-brokerage market and operational efficiency gains support upside potential to analyst targets.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
